Simon-Kucher | Global news | Pharma & Life Sciences

An overview of Simon-Kucher global news:

Asia

Simon-Kucher: South Korea’s pricing reforms spur global pharma to rethink launch plans A series of major healthcare policy reforms is reshaping South Korea’s pharmaceutical landscape, prompting global drugmakers to rethink the country’s role in their launch and pricing strategies, write Bumjin Namkoong and Sydney Baek from Simon-Kucher.
24 July 2026
China

China’s National Reimbursement Drug List (NRDL) outlook for 2024 Since the establishment of the National Healthcare Security Administration in 2018, the National Reimbursement Drug List (NRDL) has added over 700 emergency, life-saving, and innovative drugs.
08 October 2024
Saudi Arabia

SFDA guidelines for the evaluation of economic studies: Impact for new drug launches With the aim to improve decision-making processes for pricing and reimbursement of novel drugs, the Saudi Food and Drug Authority (SFDA) has issued guidelines for the evaluation of economic studies.
07 October 2024
Asia

Asia has shed its emerging status on world biopharma stage China, India, and other key markets in Asia have long been labeled as pharmerging, implying strong growth of underdeveloped markets from small bases. But that is no longer the case.
17 July 2022

More Simon-Kucher news

Out now!

Consultancy.org App

Improve your experience.

Now available in your app store.

AppStore

GooglePlay

About Consulting.us

Consultancy.org network

Consultancy.org network

Consultancy.org

Consultancy.org is the world’s premier online platform for the consulting industry with 12 websites globally. Consultancy.org works with 600+ leading consultancies in 100+ countries.

AppStore

GooglePlay